This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Pol, MD
Hôpital Avicenne Bobigny, France

JAMA. 1988;259(8):1180.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Drs Schwartz and McDonald¹ recently described two cases of cholesterol embolization syndrome occurring after receiving intravenous streptokinase therapy for myocardial infarction.

I disagree with them about their conclusion. Cholesterol embolization syndrome occurs spontaneously but has been described after vascular surgery, arteriographic procedures^2,3 including coronary angiography,² and oral anticoagulant therapy including warfarin sodium.⁴ Extensive atherosclerosis, systemic hypertension, and diabetes mellitus represent other risk factors. Furthermore, some of these conditions are frequently associated.³

In the first case reported by Drs Schwartz and McDonald, coronary arteriography preceded streptokinase treatment before the occurrence of the cholesterol embolization syndrome. In the second case, after the streptokinase had been given, coronary arteriography and two weeks of warfarin therapy followed before the cholesterol embolization syndrome developed.

There is therefore no reason to blame the intravenous streptokinase therapy, and so the title of this article is inappropriate and misleading.

Cholesterol . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?